Macquarie analyst Natsuko Douglas downgraded Cosmos Pharmaceuticals Corp. (3349:JP) (OTC: CSMYF) from Outperform to Neutral with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE